Bactiguard Holding AB (publ) (BACTI-B) - Total Assets

Latest as of March 2026: Skr537.34 Million SEK ≈ $57.83 Million USD

Based on the latest financial reports, Bactiguard Holding AB (publ) (BACTI-B) holds total assets worth Skr537.34 Million SEK (≈ $57.83 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Bactiguard Holding AB (publ) debt service capacity to assess how comfortably operating cash covers total debt obligations.

Bactiguard Holding AB (publ) - Total Assets Trend (2008–2025)

This chart illustrates how Bactiguard Holding AB (publ)'s total assets have evolved over time, based on quarterly financial data. See Bactiguard Holding AB (publ) book value and equity for net asset value and shareholders' equity analysis.

Bactiguard Holding AB (publ) - Asset Composition Analysis

Current Asset Composition (December 2025)

Bactiguard Holding AB (publ)'s total assets of Skr537.34 Million consist of 22.8% current assets and 77.2% non-current assets.

Asset Category Amount (SEK) % of Total Assets
Cash & Equivalents Skr44.26 Million 8.1%
Accounts Receivable Skr45.95 Million 8.4%
Inventory Skr21.88 Million 4.0%
Property, Plant & Equipment Skr93.34 Million 17.1%
Intangible Assets Skr51.93 Million 9.5%
Goodwill Skr248.82 Million 45.7%

Asset Composition Trend (2008–2025)

This chart illustrates how Bactiguard Holding AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see BACTI-B stock market capitalisation.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Bactiguard Holding AB (publ)'s current assets represent 22.8% of total assets in 2025, an increase from 0.0% in 2008.
  • Cash Position: Cash and equivalents constituted 8.1% of total assets in 2025, up from 0.0% in 2008.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 54.0% of total assets, an increase from 0.0% in 2008.
  • Asset Diversification: The largest asset category is goodwill at 45.7% of total assets.

Bactiguard Holding AB (publ) Competitors by Total Assets

Key competitors of Bactiguard Holding AB (publ) based on total assets are shown below.

Company Country Total Assets
Cochlear Ltd
AU:COH
Australia AU$2.83 Billion
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
Germany €2.83 Billion
Novocure Ltd
NASDAQ:NVCR
USA $787.93 Million
Sinocare Inc
SHE:300298
China CN¥6.25 Billion
L&C Bio Co. Ltd
KQ:290650
Korea ₩497.94 Billion
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
China CN¥3.71 Billion
Sequana Medical NV
BR:SEQUA
Belgium €14.57 Million
Oncosil Medical Ltd
AU:OSL
Australia AU$7.13 Million

Bactiguard Holding AB (publ) - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.67 1.36 2.40
Quick Ratio 1.32 1.13 1.74
Cash Ratio 0.00 0.49 0.21
Working Capital Skr49.02 Million Skr34.16 Million Skr69.81 Million

Bactiguard Holding AB (publ) - Advanced Valuation Insights

This section examines the relationship between Bactiguard Holding AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.05
Latest Market Cap to Assets Ratio 0.10
Asset Growth Rate (YoY) -16.9%
Total Assets Skr545.06 Million
Market Capitalization $55.79 Million USD

Valuation Analysis

Below Book Valuation: The market values Bactiguard Holding AB (publ)'s assets below their book value (0.10x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Bactiguard Holding AB (publ)'s assets decreased by 16.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Bactiguard Holding AB (publ) (2008–2025)

The table below shows the annual total assets of Bactiguard Holding AB (publ) from 2008 to 2025.

Year Total Assets Change
2025-12-31 Skr545.06 Million
≈ $58.66 Million
-16.90%
2024-12-31 Skr655.91 Million
≈ $70.59 Million
-0.95%
2023-12-31 Skr662.17 Million
≈ $71.26 Million
-18.02%
2022-12-31 Skr807.70 Million
≈ $86.92 Million
-4.90%
2021-12-31 Skr849.29 Million
≈ $91.40 Million
+25.78%
2020-12-31 Skr675.22 Million
≈ $72.66 Million
+5.28%
2019-12-31 Skr641.37 Million
≈ $69.02 Million
+9.17%
2018-12-31 Skr587.48 Million
≈ $63.22 Million
-6.06%
2017-12-31 Skr625.39 Million
≈ $67.30 Million
-1.06%
2016-12-31 Skr632.07 Million
≈ $68.02 Million
-6.53%
2015-12-31 Skr676.25 Million
≈ $72.77 Million
-16.63%
2014-12-31 Skr811.13 Million
≈ $87.29 Million
+13.09%
2013-12-31 Skr717.23 Million
≈ $77.19 Million
+1.93%
2012-12-31 Skr703.63 Million
≈ $75.72 Million
+8.13%
2011-12-31 Skr650.74 Million
≈ $70.03 Million
+20.54%
2010-12-31 Skr539.84 Million
≈ $58.10 Million
-12.84%
2009-12-31 Skr619.36 Million
≈ $66.65 Million
-10.27%
2008-12-31 Skr690.26 Million
≈ $74.28 Million
--

About Bactiguard Holding AB (publ)

ST:BACTI-B Sweden Medical Devices
Market Cap
$55.79 Million
Skr518.43 Million SEK
Market Cap Rank
#21435 Global
#395 in Sweden
Share Price
Skr16.70
Change (1 day)
+0.30%
52-Week Range
Skr14.75 - Skr34.70
All Time High
Skr205.00
About

Bactiguard Holding AB (publ), a medTech company, provides infection prevention technology and solutions in orthopedics, cardiology, neurology, urology, and vascular access areas. It also operates through license partnerships with global MedTech companies that apply the technology to medical devices and sell them under own brand and co-branded. The company also has a portfolio of wound management … Read more